NatureWise Biotech & Medicals Corporation (4732.TWO)
TWD 20.0
(-1.23%)
TWD 20.0
(-1.23%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 10.54 Million | 17.48 Million | 29.06 Million | 80.09 Million | 40.96 Million | -20.59 Million |
| Net Income | 10.12 Million | 30.02 Million | 30.8 Million | 65.31 Million | 39.69 Million | -14.81 Million |
| Depreciation & Amortization | 10.41 Million | 10.93 Million | 11.29 Million | 12.05 Million | 11.55 Million | 7.94 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 6.82 Million | 1.7 Million | - | - | - | - |
| Change in working capital | -11.9 Million | -23.48 Million | -12.95 Million | 8.79 Million | -13.69 Million | -12.39 Million |
| Other non-cash items | 22.94 Million | 35.1 Million | 29.68 Million | 13.47 Million | 59.8 Million | 30.68 Million |
| Investing Cash Flow | -19.71 Million | -51.93 Million | -32.04 Million | -143.72 Million | -48.32 Million | 9.9 Million |
| Investments in PPE | -1.41 Million | -152 Thousand | -176 Thousand | -2.72 Million | -2.88 Million | -1.67 Million |
| Acquisitions | - | 10 Thousand | - | - | - | -1.95 Million |
| Investment purchases | -18.3 Million | -52.39 Million | -32.65 Million | -141 Million | -45.43 Million | - |
| Sales/Maturities of investments | - | - | - | - | - | 13.53 Million |
| Other Investing Activities | -777 Thousand | 601 Thousand | 778 Thousand | -1.4 Million | - | - |
| Financing Cash Flow | -28.04 Million | -22.35 Million | -3.73 Million | -8.39 Million | 232.61 Million | 2.57 Million |
| Debt repayment | -613 Thousand | -3.62 Million | -4.83 Million | -4.31 Million | -1.38 Million | -2.57 Million |
| Dividends payments | -24.64 Million | -14.78 Million | -4.65 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | 230 Million | - |
| Other Financing Activities | -4.01 Million | - | - | - | 4 Million | - |
| Accounts receivables | 9.18 Million | 1.09 Million | -5.46 Million | 4.3 Million | -31.57 Million | -8.85 Million |
| Accounts payables | 13.57 Million | -10.56 Million | 16.36 Million | -8.62 Million | 3.1 Million | 3.46 Million |
| Inventory | -22.94 Million | -3.75 Million | -18.09 Million | 8.88 Million | -4.81 Million | -10.73 Million |
| Other working capital | -11.71 Million | -10.26 Million | -5.76 Million | 4.23 Million | 19.59 Million | 3.74 Million |
| Cash at beginning of period | 98.97 Million | 155.56 Million | 162.57 Million | 254.53 Million | 30.42 Million | 38.75 Million |
| Cash at end of period | 112.55 Million | 98.97 Million | 155.56 Million | 162.57 Million | 254.53 Million | 30.42 Million |
| Capital Expenditure | -1.41 Million | -152 Thousand | -176 Thousand | -2.72 Million | -2.88 Million | -1.67 Million |
| Effect of forex changes on cash | -249 Thousand | 217 Thousand | -118 Thousand | 277 Thousand | - | - |
| Net cash flow / Change in cash | 13.57 Million | -56.58 Million | -7.01 Million | -91.95 Million | 224.11 Million | -8.33 Million |
| Free Cash Flow | 9.13 Million | 17.33 Million | 28.88 Million | 77.37 Million | 38.07 Million | -22.27 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.51 Million | 4.51 Million | 6.72 Million | 10.12 Million | 3.36 Million | 3.39 Million |
| Depreciation & Amortization | 2.74 Million | 2.74 Million | 5.23 Million | 10.41 Million | 2.61 Million | 5.18 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 1.58 Million | 1.58 Million | - | 6.82 Million | 1.7 Million | - |
| Change in working capital | 7.03 Million | 7.03 Million | -30.03 Million | -11.9 Million | -23.24 Million | 18.13 Million |
| Other non-cash items | -8.45 Million | -8.45 Million | 38.2 Million | 22.94 Million | 33.54 Million | -15.26 Million |
| Investing Cash Flow | -3.36 Million | -3.36 Million | 7.46 Million | -19.71 Million | 3.73 Million | -27.17 Million |
| Investments in PPE | -1.69 Million | - | -415 Thousand | -1.41 Million | - | -691 Thousand |
| Acquisitions | 7.5 Million | - | - | - | - | - |
| Investment purchases | -5.02 Million | - | 8.18 Million | -18.3 Million | - | -26.48 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -3.36 Million | -3.36 Million | - | -777 Thousand | 3.73 Million | - |
| Financing Cash Flow | 2.61 Million | 2.61 Million | -24.71 Million | -28.04 Million | -13.32 Million | -3.32 Million |
| Debt repayment | -10 Thousand | - | -1.93 Million | -613 Thousand | - | -1.32 Million |
| Dividends payments | - | - | -24.64 Million | -24.64 Million | -12.32 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 2.61 Million | 2.61 Million | - | - | -1 Million | - |
| Accounts receivables | 5.24 Million | 5.24 Million | -11.86 Million | 9.18 Million | -6.08 Million | 21.04 Million |
| Accounts payables | -19.6 Million | - | 19.58 Million | 13.57 Million | - | -6 Million |
| Inventory | 6.17 Million | 6.17 Million | -34.37 Million | -22.94 Million | -17.18 Million | 11.42 Million |
| Other working capital | -4.37 Million | -4.37 Million | -3.38 Million | -11.71 Million | 30.5 Thousand | -8.32 Million |
| Cash at beginning of period | 112.55 Million | - | 95.62 Million | 98.97 Million | 95.62 Million | 98.97 Million |
| Cash at end of period | 126.17 Million | 6.81 Million | 112.55 Million | 112.55 Million | 104.08 Million | 95.62 Million |
| Capital Expenditure | -1.69 Million | - | -415 Thousand | -1.41 Million | - | -691 Thousand |
| Effect of forex changes on cash | 131.5 Thousand | 131.5 Thousand | - | -249 Thousand | 73 Thousand | - |
| Net cash flow / Change in cash | 13.62 Million | 6.81 Million | 16.93 Million | 13.57 Million | 8.46 Million | -3.35 Million |
| Free Cash Flow | 5.72 Million | 7.42 Million | -17.41 Million | 9.13 Million | 17.98 Million | 26.85 Million |
TSE
4584
ENJOY
ETTE
SCFFF
4220